A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG). (Q44557341)
Jump to navigation
Jump to search
scientific article published in September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG). |
scientific article published in September 2003 |
Statements
1 reference
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG). (English)
1 reference
W Jedrzejczak
1 reference
A Dmoszyńska
1 reference
J Hołowiecki
1 reference
S Grosicki
1 reference
T Robak
1 reference
E Lech-Marańda
1 reference
A Wierzbowska
1 reference
A Hellmann
1 reference
A Skotnicki
1 reference
K Kuliczkowski
1 reference
A Wrzesień-Kuś
1 reference
S Kyrcz-Krzemień
1 reference
Polish Adult Leukemia Group
1 reference
M Kowal
1 reference
S Maj
1 reference
1 September 2003
1 reference
1 reference
71
1 reference
3
1 reference
155-162
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference